Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Induces rhoa activation and activates nppa transcription and myofibrillar organization through the rho/rock signaling pathway (By similarity). Additionally we are shipping MURC Kits (7) and MURC Proteins (7) and many more products for this protein.
Showing 10 out of 24 products:
Human Polyclonal MURC Primary Antibody for IHC, IHC (p) - ABIN4336752
Faggi, Codenotti, Poliani, Cominelli, Chiarelli, Colombi, Vezzoli, Monti, Bono, Tulipano, Fiorentini, Zanola, Lo, Parton, Keller, Fanzani: MURC/cavin-4 Is Co-Expressed with Caveolin-3 in Rhabdomyosarcoma Tumors and Its Silencing Prevents Myogenic Differentiation in the Human Embryonal RD Cell Line. in PLoS ONE 2015
Human Polyclonal MURC Primary Antibody for ICC, IF - ABIN4336750
Tassin, Leroy, Laoudj-Chenivesse, Wauters, Vanderplanck, Le Bihan, Coppée, Wattiez, Belayew: FSHD myotubes with different phenotypes exhibit distinct proteomes. in PLoS ONE 2012
murcb mutant zebrafish, display impaired swimming capacity, skeletal muscle fibrosis and T-tubule abnormalities during development.
MURC/cavin-4, especially in combination with Cav-3, may play a consistent role in the differentiation process of rhabdomyosarcoma.
MURC mutations impart loss-of-function effects on MURC functions and probably are causal variants in human dilated cardiomyopathy
MURC modulates RhoA signaling, and MURC plays an important role in the development of cardiac dysfunction and conduction disturbance with increased vulnerability to atrial arrhythmias.
MURC binds to Cav1 and inhibits the association of Cav1 with the active form of Galpha13, resulting in the facilitated association of the active form of Galpha13 with p115RhoGEF. These results reveal that MURC has a function in the development of pulmonary hypertension through modulating Rho/ROCK signaling.
The MURC/Cavin-4 in vascular smooth muscle cells modulates abdominal aortic aneurysm (AAA) progression at the early stage via the activation of JNK and MMP-9. MURC/Cavin-4 is a potential therapeutic target against AAA progression.
MURC/Cavin-4 facilitates recruitment of ERK to caveolae and concentric cardiac hypertrophy induced by alpha1-adrenergic receptors.
findings suggest that MURC is involved in the skeletal myogenesis that results from modulation of myogenin expression and ERK activation; MURC may play pivotal roles in the molecular mechanisms of skeletal myogenic differentiation
Data show that MURC/Cavin-4 forms a multiprotein complex that associates with caveolae, and identify Cavin-4 as a novel muscle disease candidate caveolar protein.
Induces rhoa activation and activates nppa transcription and myofibrillar organization through the rho/rock signaling pathway (By similarity).
muscle-related coiled-coil protein
, muscle-restricted coiled-coil protein
, PTRF/SDPR family protein